Net Income (Loss) Per Share Attributable to Common Stockholders (Tables)

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Summary of Net Loss Attributable to Common Stockholders

The following table presents the calculation of basic and diluted net income (loss) per share attributable to common stockholders (in thousands, except share and per share amounts):

	Three Months Ended March 31,
	2024		2023
Basic earnings per common share:
Net income (loss) and comprehensive income (loss)	$	3,274	$	(11,867)
Less:
Accretion on convertible preferred stock	(1,328)		(653)
Net income (loss) allocated to participating securities	(661)		—
Net income (loss) attributable to common stockholders, basic (1)	$	1,285	$	(12,520)
Weighted average common shares outstanding, basic	8,740,059		8,110,387
Net income (loss) per share attributable to common stockholders, basic	$	0.15	$	(1.54)
Diluted earnings per common share:
Net income (loss) and comprehensive income (loss)	$	3,274	$	(11,867)
Less:
Accretion on convertible preferred stock	(1,328)		(653)
Effect of dilutive securities	(6,809)		—
Net loss attributable to common stockholders, diluted	$	(4,863)	$	(12,520)
Weighted average common shares outstanding, basic	8,740,059		8,110,387
Effect of dilutive securities	877,766		—
Weighted average common shares outstanding, diluted	9,617,825		8,110,387
Net income (loss) per share attributable to common stockholders, diluted	$	(0.51)	$	(1.54)

(1) For the three months ended March 31, 2023, the Company did not allocate its net loss to participating convertible preferred stock as those shares are not obligated to share in the losses of the Company.

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table summarizes the common stock equivalents of potentially dilutive outstanding securities excluded from the computation of diluted net income (loss) per share due to their anti-dilutive effect:

	As of March 31,
	2024	2023
Stock options	463,168	529,897
RSUs	1,526,327	365,512
PRSUs	71,428	87,323
ESPP shares committed	19,388	23,817
Common stock warrants	3,102,591	9,175,282
Convertible preferred stock	5,200,802	4,373,178
Total	10,383,704	14,555,009